Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
CV indication via OptumRx standard formulary Wegovy's cardiovascular risk reduction indication is covered on the OptumRx standard formulary for UHC commercial and Medicare members with established CVD who are overweight or obese
Many people also notice early wins, like fewer food-related thoughts or cravings
This development is not just about pricing it highlights a transformational moment in the obesity and diabetes care landscape, where competition and affordability are reshaping strategies in one of the fastest-growing segments of global healthcare
PMID 28492905
Roche's key differentiation strategy is focused on managing side effects
Taking a GLP-1
US$ 27.45
US$ 26.29
US$ 20.02
US$ 24.23
US$ 20.17
US$ 28.33
US$ 28.23
